Form 4 for VIR Vir Biotechnology, Inc.
Accepted 2026-03-24 00:00:00 ET · period of report 2026-03-23 · accession 0001628280-26-020823 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-24 | 2026-03-23 | VIR | Sabatini Brent | SVP, CAO | S - Sale | $9.12 | -7,711 | 61.9K | -11% | -$70.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-23 | S | D | 7,711 | $9.12 | 61,902 | D | — | — |